Cargando…

Heterogeneity of Rabies Vaccination Recommendations across Asia

Asian countries bear the greatest burden of the disease, with a majority (59%) of rabies-related deaths occurring in Asia. In order to promote best practices, we summarized national human vaccination guidelines across this region, to highlight differences and similarities and to discuss the aspects...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchy, Philippe, Preiss, Scott, Singh, Ved, Mukherjee, Piyali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082101/
https://www.ncbi.nlm.nih.gov/pubmed/30270882
http://dx.doi.org/10.3390/tropicalmed2030023
_version_ 1783345765045764096
author Buchy, Philippe
Preiss, Scott
Singh, Ved
Mukherjee, Piyali
author_facet Buchy, Philippe
Preiss, Scott
Singh, Ved
Mukherjee, Piyali
author_sort Buchy, Philippe
collection PubMed
description Asian countries bear the greatest burden of the disease, with a majority (59%) of rabies-related deaths occurring in Asia. In order to promote best practices, we summarized national human vaccination guidelines across this region, to highlight differences and similarities and to discuss the aspects that would benefit from updates. National management guidelines for rabies were retrieved from various sources to extract information on rabies pre- and post-exposure prophylaxis (PrEP, and PEP), booster vaccination, and route of administration. Rabies guidelines recommendations for wound management and PrEP across Asia are broadly aligned to the World Health Organization (WHO) guidelines. For PEP, the 5-dose Essen, and the 4-dose Zagreb are the regimens of choice for intramuscular (IM), and the Thai Red Cross regimen for intradermal (ID), administration. Several national guidelines have yet to endorse ID vaccine administration. Most guidelines recommend rabies immunoglobulin in category III exposures. Booster recommendations are not included in all guidelines, with limited clarity on booster requirement across the spectrum of risk of rabies exposure. In conclusion, national recommendations across Asian countries differ and while some guidelines are closely aligned to the WHO recommendations, resource-saving ID administration and use of rational abbreviated schedules have yet to be endorsed.
format Online
Article
Text
id pubmed-6082101
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60821012018-09-24 Heterogeneity of Rabies Vaccination Recommendations across Asia Buchy, Philippe Preiss, Scott Singh, Ved Mukherjee, Piyali Trop Med Infect Dis Review Asian countries bear the greatest burden of the disease, with a majority (59%) of rabies-related deaths occurring in Asia. In order to promote best practices, we summarized national human vaccination guidelines across this region, to highlight differences and similarities and to discuss the aspects that would benefit from updates. National management guidelines for rabies were retrieved from various sources to extract information on rabies pre- and post-exposure prophylaxis (PrEP, and PEP), booster vaccination, and route of administration. Rabies guidelines recommendations for wound management and PrEP across Asia are broadly aligned to the World Health Organization (WHO) guidelines. For PEP, the 5-dose Essen, and the 4-dose Zagreb are the regimens of choice for intramuscular (IM), and the Thai Red Cross regimen for intradermal (ID), administration. Several national guidelines have yet to endorse ID vaccine administration. Most guidelines recommend rabies immunoglobulin in category III exposures. Booster recommendations are not included in all guidelines, with limited clarity on booster requirement across the spectrum of risk of rabies exposure. In conclusion, national recommendations across Asian countries differ and while some guidelines are closely aligned to the WHO recommendations, resource-saving ID administration and use of rational abbreviated schedules have yet to be endorsed. MDPI 2017-07-06 /pmc/articles/PMC6082101/ /pubmed/30270882 http://dx.doi.org/10.3390/tropicalmed2030023 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Buchy, Philippe
Preiss, Scott
Singh, Ved
Mukherjee, Piyali
Heterogeneity of Rabies Vaccination Recommendations across Asia
title Heterogeneity of Rabies Vaccination Recommendations across Asia
title_full Heterogeneity of Rabies Vaccination Recommendations across Asia
title_fullStr Heterogeneity of Rabies Vaccination Recommendations across Asia
title_full_unstemmed Heterogeneity of Rabies Vaccination Recommendations across Asia
title_short Heterogeneity of Rabies Vaccination Recommendations across Asia
title_sort heterogeneity of rabies vaccination recommendations across asia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082101/
https://www.ncbi.nlm.nih.gov/pubmed/30270882
http://dx.doi.org/10.3390/tropicalmed2030023
work_keys_str_mv AT buchyphilippe heterogeneityofrabiesvaccinationrecommendationsacrossasia
AT preissscott heterogeneityofrabiesvaccinationrecommendationsacrossasia
AT singhved heterogeneityofrabiesvaccinationrecommendationsacrossasia
AT mukherjeepiyali heterogeneityofrabiesvaccinationrecommendationsacrossasia